Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody

1. BOLAKI M, ANTONIOU KM. Combined Pulmonary Fibrosis and Emphysema. Semin Respir Crit Care Med 2020; 41(2): 17-183.10.1055/s-0040-1708058 Search in Google Scholar

2. HAGE R, GAUTSCHI F, STEINACK C, SCHUURMANS MM. Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management. Int J Chron Obstruct Pulmon Dis 2021; 16: 167-77.10.2147/COPD.S286360 Search in Google Scholar

3. KOO BS, PARK KY, LEE HJ, KIM HJ, AHN HS, YIM SY, et al. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther 2021; 23(1): 100.10.1186/s13075-021-02494-y Search in Google Scholar

4. COTTIN V, NUNES H, MOUTHON L, GAMONDES D, LAZOR R, HACHULLA E, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63(1): 295-304.10.1002/art.30077 Search in Google Scholar

5. HAMAGUCHI Y, FUJIMOTO M, MATSUSHITA T, KAJI K, KOMURA K, HASEGAWA M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-t-RNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 2013; 8: e60442.10.1371/journal.pone.0060442 Search in Google Scholar

6. KOREEDA Y, HIGASHIMOTO I, YAMAMOTO M, TAKAHASHI M, KAJI K, FUJIMOTO M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010; 49(5): 361-9.10.2169/internalmedicine.49.2889 Search in Google Scholar

7. DAIDO W, YAMASAKI M, MORIO Y, FUNAISHI K, ISHIYAMA S, DEGUCHI N, et al. A rare combination of dermatomyositis, IP, and lung cancer in a patient treated with immunosuppressive therapy and chemotherapy. Intern Med. 2018; 57(6): 849-53.10.2169/internalmedicine.9642-17 Search in Google Scholar

8. TARGOFF IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20(4): 857-80.10.1016/S0889-857X(21)00070-3 Search in Google Scholar

9. MARGUERIE C, BUNN CC, BEYNON HL, BERNSTEIN RM, HUGHES JM, SO AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77(282): 1019-38.10.1093/qjmed/77.1.10192267280 Search in Google Scholar

10. LOVE LA, LEFF RL, FRASER DD, TARGOFF IN, DALAKAS M, PLOTZ PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70(6): 360-74.10.1097/00005792-199111000-000021659647 Search in Google Scholar

11. HIRAKATA M, NAGAI S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12(6): 501-8.10.1097/00002281-200011000-0000511092199 Search in Google Scholar

12. YOKOI E, HARUTA Y, WADA Y, ITO H, MACHIDA K, MATSUO M. Three cases of interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies complicated by gynecological cancer. Nihon Kokyuuki Gakkai Zassi 2018: 7(4): 229-32(in Japanese). Search in Google Scholar

13. SHIKANO K, KANEKO K, KABURAKI K, ISOBE K, KAWABE K, HOMMA S, et al. Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma. Scand J Rheumatol 2020; 49(1): 82-83.10.1080/03009742.2019.159630931135242 Search in Google Scholar

14. FUJITA Y, HIRANO S, YONESHIM Y, IZUMI S, TAKEDA Y, SUGIYAMA H, et al. A case of acute exacerbation of interstitial pneumonia complicated with dermatomyositis during treatment for lung cancer, and literature review. Nihon Kokyuki Gakkai Zasshi 2011; 49(2): 108-15 (in Japanese). Search in Google Scholar

• The Role of Tei Index added to the GRACE risk score for prediction of in-hospital MACE after acute myocardial infarction

• Comparison of Salivary Interleukin-6, Interleukin-8, C - reactive protein levels and Total Antioxidants Capacity of Obese Individuals with Normal Weight Ones

• Intravenous Treatment Adherence of Patients with Chronic Inflammatory Rheumatic Diseases During the COVID-19 Pandemic: Experience of a Single Center

• Elevated interleukin -17A levels despite reduced microRNA-326 gene expression in celiac disease patients under gluten-free diet

• Stroke risk scores for prediction of mortality and hemorrhages in atrial fibrillation patients

• A Pilot Study of Changes in Urinary Podocalyxin Levels during Normal Pregnancy and Labor

• Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody

• Validation of Salivary Glucose as a Screening Tool of Diabetes Mellitus

• Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations